Torasemide

托拉塞米

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTorasemide
Drug Alias Nametorasemida托拉噻咪托洛塞米torasemidum托拉赛米 +[27] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitors
TargetsSodium-(potassium)-chloride cotransporter 2
Therapy Area/IndicationsFoodborne DiseasesEdemaHypertension +[6] 
Global Approved IndicationsEdemaHypertension
Approved Indications in ChinaEdemaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1993/08/23
Country/TerritoryUnited StatesIndiaKazakhstan +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active CompaniesBerlin-Chemie Ag (Menarini Group)F. Hoffmann-La Roche LtdSarfez Pharmaceuticals Inc
Inactive CompaniesPharmobedient Consulting LLCThe University Of Texas Health Science Center At HoustonPar Pharmaceutical Inc
Active IndicationsEdemaHypertensionHeart Failure +[4] 
Inactive IndicationsFoodborne DiseasesPre-Eclampsia

Other Information

ATC CodeC03CA04
Related LinksWikipediaDrugBankKEGG